All lobbying clients

McKesson Corporation & Its Affiliate U.S. Oncology

McKesson Corporation & Its Affiliate U.S. Oncology has lobbied on its own behalf in 7 filings since 2025, with $5,390,000 in reported spending; the newest was posted October 20, 2026.

As filed: MCKESSON CORPORATION & ITS AFFILIATE U.S. ONCOLOGY. Client based in Texas.

$5,390,000 Reported spend

7 Filings counted

0 Outside firms hired

23 Bills named

Spend is reported income plus in-house expenses across 7 filings. 1 further filing for this client was restated by a later amendment and is left out of every total here. Everything on this page comes from one LDA client record (132410), filed by the registrant listed below. These filings have also been reported as MCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONS.

Who filed for this client 1

McKesson Corporation & Its Affiliate U.S. Oncology $5,390,000 In-house, the client's own filings · 7 filings

Spend per registrant: fees an outside firm reported, or the costs the client reported for lobbying in-house. The rows add up to the total above.

Bills named in these filings 23

H.R. 2484
Seniors’ Access to Critical Medications Act of 2025

7 filings
H.R. 1
One Big Beautiful Bill Act

6 filings
H.R. 2120
ROCR Value Based Program Act

6 filings
H.R. 2444
Promoting Resilient Supply Chains Act of 2025

6 filings
H.R. 3164
Ensuring Community Access to Pharmacist Services Act

6 filings
H.R. 3514
Improving Seniors’ Timely Access to Care Act of 2025

6 filings
H.R. 3521
Clinical Trial Modernization Act

6 filings
H.R. 879
Medicare Patient Access and Practice Stabilization Act of 2025

6 filings
S. 1816
Improving Seniors’ Timely Access to Care Act of 2025

6 filings
S. 257
Promoting Resilient Supply Chains Act of 2025

6 filings
H.R. 4299
Protecting Patient Access to Cancer and Complex Therapies Act

5 filings
S. 3822
Break Up Big Medicine Act

3 filings
H.R. 3173
Improving Seniors’ Timely Access to Care Act of 2022

1 filing
S. 3018
Improving Seniors’ Timely Access to Care Act of 2021

1 filing
H.R. 2474
Strengthening Medicare for Patients and Providers Act

1 filing
H.R. 2630
Safe Step Act

1 filing
H.R. 3561
PATIENT Act of 2023

1 filing
H.R. 4473
Medicare Patient Access to Cancer Treatment Act

1 filing
H.R. 5376
Share the Savings with Seniors Act

1 filing
S. 127
Pharmacy Benefit Manager Transparency Act of 2023

1 filing
S. 1339
Pharmacy Benefit Manager Reform Act

1 filing
H.R. 4011
Community Paramedicine Act of 2025

1 filing
S. 652
Protecting Patients from Deceptive Drug Ads Act

1 filing

Reported by year 2 years

2026 $2,000,000 3 filings
2025 $3,390,000 4 filings

Issues lobbied 5

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

Agencies and chambers lobbied 7

Health & Human Services, Dept of (HHS) 7
HOUSE OF REPRESENTATIVES 7
SENATE 7
Centers For Medicare and Medicaid Services (CMS) 6
White House Office 6
Office of Management & Budget (OMB) 2
Executive Office of the President (EOP) 1

Recent filings 8 total

Q3 report

McKesson Corporation & Its Affiliate U.S. Oncology

3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $610,000 expenses · posted Oct 20, 2026

View → Q2 report

McKesson Corporation & Affiliates U.S. Oncology and RX Savings Solutions (Formerly McKesson Corp.)

2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $530,000 expenses · posted Jul 20, 2026

View → Q1 report

McKesson Corporation & Affiliates U.S. Oncology and RX Savings Solutions (Formerly McKesson Corp.)

1st Quarter 2026 (Jan 1 - Mar 31) · House · Senate · $860,000 expenses · posted Apr 20, 2026

View → Q4 report

McKesson Corporation & Affiliates U.S. Oncology and RX Savings Solutions (Formerly McKesson Corp.)

4th Quarter 2025 (Oct 1 - Dec 31) · House · Senate · $1,180,000 expenses · posted Jan 19, 2026

View → Q3 report

McKesson Corporation & Affiliates U.S. Oncology and RX Savings Solutions (Formerly McKesson Corp.)

3rd Quarter 2025 (July 1 - Sep 30) · House · Senate · $530,000 expenses · posted Oct 20, 2025

View → Q2 report

McKesson Corporation & Affiliates U.S. Oncology and RX Savings Solutions (Formerly McKesson Corp.)

2nd Quarter 2025 (Apr 1 - June 30) · House · Senate · $460,000 expenses · posted Jul 17, 2025

View → Q1 amendment

McKesson Corporation & Affiliates U.S. Oncology and RX Savings Solutions (Formerly McKesson Corp.)

1st Quarter 2025 (Jan 1 - Mar 31) · House · Senate · $1,220,000 expenses · posted Apr 24, 2025

View → Q1 report

McKesson Corporation & Affiliates U.S. Oncology and RX Savings Solutions (Formerly McKesson Corp.) Amended

1st Quarter 2025 (Jan 1 - Mar 31) · House · Senate · $1,220,000 expenses · posted Apr 21, 2025

View →

Keep going

Filings through October 20, 2026, the newest posted date on this record. Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.